CervoMed Inc. CRVO
Set alert
1.60 USD -0.04 -2.44%
As of Nov 3, 11:06 AM ET
1.55 Day range 1.70
1.55 52-week range 10.00
- YTD
- -79.75%
- 1 year
- -77.21%
- Open
- 1.64
- Prev close
- 1.64
- Mkt cap
- 24.19M
- Vol
- 201.74K
- Avg vol
- 292.50K
- EPS
- -3.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.55
- High
- 1.70
- Forward P/E
- -0.87
- Beta
- 0.00
- Short ratio
- 15.72
- Inst. own
- 42.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 1, 2024
- 50-d avg
- 10.02
- 200-d avg
- 16.41
- 1y target
- 20.00
5D chart
Signals (107)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 3:20 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 2:15 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:05 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 1:50 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:35 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 1:20 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 1:15 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 1:15 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 12:55 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 12:45 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 12:45 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 12:15 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 11:40 AM | 23 hours ago |
| MACD: Sell Signal | Nov 2, 11:10 AM | 23 hours ago |
| SMA: Bearish | Nov 2, 11:05 AM | 1 day ago |
| SMA: Bearish | Nov 2, 11:05 AM | 1 day ago |
| SMA: Bullish | Nov 2, 10:20 AM | 1 day ago |
| SMA: Bullish | Nov 2, 10:20 AM | 1 day ago |
Newest 20 of 107.
Analyst view
Consensus: hold
Hold
Price target (mean) 20.00 +1150.0% upside
Now 1.60
- Target (low)
- 4.00
- Target (mean)
- 20.00
- Target (high)
- 34.00
Ratings (0m) 8 2 buy · 5 hold · 1 sell
- Strong buy1
- Buy1
- Hold5
- Sell1
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 6
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.445 | -0.52 – -0.33 | -0.95 | +53.2% | 1.82M | -27.0% | 7 |
| Next quarter | -0.5775 | -0.67 – -0.52 | -0.41 | -40.8% | 1.32M | -43.9% | 4 |
| Current year | -1.51 | -1.73 – -1.34 | -0.82 | -84.4% | 9.09M | +27.2% | 7 |
| Next year | -1.86 | -3.46 – -0.94 | -1.51 | -22.8% | 5.55M | -38.9% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Dec 11, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 11, 2024 | Chardan Capital | Downgrade | Buy | Neutral |
| Dec 10, 2024 | Jones Trading | Downgrade | Buy | Hold |
| Dec 10, 2024 | D. Boral Capital | Downgrade | Buy | Hold |
| Dec 5, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 5, 2024 | Roth MKM | Initiated | — | Buy |
| Nov 27, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 18, 2024 | D. Boral Capital | Initiated | — | Buy |
| Nov 14, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Sep 18, 2024 | Chardan Capital | Initiated | — | Buy |
| Jul 26, 2024 | Morgan Stanley | Initiated | — | Overweight |
| Jul 25, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 8, 2024 | Brookline Capital | Initiated | — | Buy |
| May 29, 2024 | Jones Trading | Initiated | — | Buy |
| Apr 8, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 15, 2024 | Canaccord Genuity | Initiated | — | Buy |